Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat for graft protection in kidney transplantation
ChiCTR2000030960Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of roxadustat in end-stage kidney disease (ESKD) (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Delayed graft function, Degree of decrease in creatinine in the early postoperative period and 1 more. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
roxadustat
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2000030960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030960.